Morpholino

MO3-lclat1

ID

ZDB-MRPHLNO-081110-3

Name

MO3-lclat1

Previous Names

lycat-MO3 (1)
MO3-lycat (1)

Target

lclat1 (1)

Sequence

5' - CTGAACACACACACTGACCGAAGC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO3-lclat1

Expressed Gene	Anatomy	Figures
etsrp	anterior lateral plate mesoderm posterior lateral plate mesoderm vascular cord	Fig. 3, Fig. S3 from Xiong et al., 2008
etv6	intermediate cell mass of mesoderm	Fig. 1 from Rasighaemi et al., 2015
fli1	anterior lateral plate mesoderm posterior lateral plate mesoderm	Fig. 3 from Xiong et al., 2008
gata1a	lateral plate mesoderm	Fig. 4 from Xiong et al., 2008
kdrl	anterior lateral plate mesoderm posterior lateral plate mesoderm	Fig. 3 from Xiong et al., 2008
lmo2	anterior lateral plate mesoderm posterior lateral plate mesoderm	Fig. 4 from Xiong et al., 2008
tal1	anterior lateral plate mesoderm intermediate cell mass of mesoderm posterior lateral plate mesoderm	Fig. 1 from Rasighaemi et al., 2015 Fig. 4 from Xiong et al., 2008
tie1	posterior cardinal vein vascular cord	Fig. S3 from Xiong et al., 2008

Phenotype

Phenotype resulting from MO3-lclat1

Phenotype	Fish	Figures
blood cell decreased amount, abnormal	WT + MO3-lclat1	Fig. 1 from Xiong et al., 2008
blood vasculature decreased amount, abnormal	zf528Tg + MO3-lclat1	Fig. 1 from Xiong et al., 2008
blood vessel development disrupted, abnormal	WT + MO3-lclat1	Fig. 1, Fig. S2, Fig. S3 from Xiong et al., 2008
endocardium aplastic, abnormal	zf528Tg + MO3-lclat1	Fig. 1, Fig. S2 from Xiong et al., 2008
endothelial cell decreased amount, abnormal	zf528Tg + MO3-lclat1	Fig. S2 from Xiong et al., 2008
endothelial cell development disrupted, abnormal	zf528Tg + MO3-lclat1	Fig. S2 from Xiong et al., 2008
intermediate cell mass of mesoderm etv6 expression decreased amount, abnormal	WT + MO3-lclat1	Fig. 1 from Rasighaemi et al., 2015
intermediate cell mass of mesoderm tal1 expression decreased amount, abnormal	WT + MO3-lclat1	Fig. 1 from Rasighaemi et al., 2015

Phenotype of all Fish created by or utilizing MO3-lclat1

Phenotype	Fish	Conditions	Figures
blood cell decreased amount, abnormal	WT + MO3-lclat1	standard conditions	Fig. 1 from Xiong et al., 2008
blood vessel development disrupted, abnormal	WT + MO3-lclat1	standard conditions	Fig. 1, Fig. S3 from Xiong et al., 2008
intermediate cell mass of mesoderm etv6 expression decreased amount, abnormal	WT + MO3-lclat1	standard conditions	Fig. 1 from Rasighaemi et al., 2015
blood vasculature decreased amount, abnormal	WT + MO3-lclat1	standard conditions	Fig. 1 from Xiong et al., 2008
endocardium aplastic, abnormal	WT + MO3-lclat1	standard conditions	Fig. 1 from Xiong et al., 2008
intermediate cell mass of mesoderm tal1 expression decreased amount, abnormal	WT + MO3-lclat1	standard conditions	Fig. 1 from Rasighaemi et al., 2015
blood vessel development disrupted, abnormal	la781Tg + MO3-lclat1	standard conditions	Fig. 1 from Xiong et al., 2008
blood vasculature decreased amount, abnormal	la781Tg + MO3-lclat1	standard conditions	Fig. 1 from Xiong et al., 2008
endothelial cell decreased amount, abnormal	zf528Tg + MO3-lclat1	standard conditions	Fig. S2 from Xiong et al., 2008
blood vessel development disrupted, abnormal	zf528Tg + MO3-lclat1	standard conditions	Fig. 1, Fig. S2 from Xiong et al., 2008
endocardium aplastic, abnormal	zf528Tg + MO3-lclat1	standard conditions	Fig. S2 from Xiong et al., 2008
endothelial cell development disrupted, abnormal	zf528Tg + MO3-lclat1	standard conditions	Fig. S2 from Xiong et al., 2008
blood vasculature decreased amount, abnormal	zf528Tg + MO3-lclat1	standard conditions	Fig. 1 from Xiong et al., 2008

Citations